Artículo

Mesenchymal stem cell therapy facilitates donor lung preservation by reducing oxidative damage during ischemia

Pacienza, Natalia ; Santa Cruz, Diego Mario Icon; Malvicini, Ricardo Icon; Robledo, Oscar ; Lemus Larralde, Gastón ; Bertolotti, Alejandro Mario ; Marcos, Martín ; Yannarelli, Gustavo Gabriel Icon

Otros responsables

Fecha

08/2019

Editorial

Hindawi Publishing Corporation

Revista

Stem Cells International

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

1687-9678

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Resumen

Lung transplantation is a lifesaving therapy for people living with severe, life-threatening lung disease. The high mortality rate among patients awaiting transplantation is mainly due to the low percentage of lungs that are deemed acceptable for implantation. Thus, the current shortage of lung donors may be significantly reduced by implementing different therapeutic strategies which facilitate both organ preservation and recovery. Here, we studied whether the anti-inflammatory effect of human umbilical cord-derived mesenchymal stem cells (HUCPVCs) increases lung availability by improving organ preservation. We developed a lung preservation rat model that mimics the different stages by which donor organs must undergo before implantation. The therapeutic schema was as follows: cardiac arrest, warm ischemia (2h at room temperature), cold ischemia (1.5h at 4°C, with Perfadex), and normothermic lung perfusion with ventilation (Steen solution, 1h). After 1h of warm ischemia, HUCPVCs (1x106 cells) or vehicle were infused via the pulmonary artery. Physiologic data (pressure-volume curves) were acquired right after the cardiac arrest and at the end of the perfusion. Interestingly, although lung edema did not change among groups, lung compliance dropped a 34% in the HUCPVCs-treated group, while the vehicle group showed a stronger reduction (69%, p<0.0001). Histologic assessment demonstrated less overall inflammation in HUCPVCs-treated lungs. In addition, MPO activity, a neutrophil marker, was reduced by 41% compared with vehicle (p<0.01). MSCs therapy significantly decreased tissue oxidative damage by controlling reactive oxygen species production. Accordingly, catalase and superoxide dismutase enzyme activities remained at baseline levels. In conclusion, these results demonstrate that the anti-inflammatory effect of MSCs protects donor lungs against ischemic injury and postulate MSCs therapy as a novel tool for organ preservation.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa